Loading clinical trials...

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine | Clinical Trials | Clareo Health

COMPLETEDEARLY Phase 1

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

NCT02546752•Regenstrief Institute, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+2 more

Interventions

THEO

Locations

5

United States

Locations (5)

Eskenazi Health Outpatient Care Center

Indianapolis, Indiana, United States

Eskenazi Health Center Blackburn

Indianapolis, Indiana, United States

Eskenazi Health Center Forest Manor

Indianapolis, Indiana, United States

Eskenazi Health West 38th Street

Indianapolis, Indiana, United States

Eskenazi Health Pecar

Indianapolis, Indiana, United States

Key Dates

Start Date

September 1, 2015

Primary Completion Date

May 1, 2016

Completion Date

May 1, 2016

Last Updated

May 25, 2016

Related Studies

RECRUITINGPhase 2

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

NCT07407569

Human Papilloma Virus Infection Type 16

COMPLETEDPhase 3

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

NCT02733068

Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+1 more

Sponsors

Lead Sponsor

Regenstrief Institute, Inc.

Collaborators

Merck Sharp & Dohme LLC

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 25, 2016Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions